Abstract:Due to its aggressiveness and unusual resistance to conventional therapies, pancreatic cancer is a highly lethal gastrointestinal malignancy with poor prognosis. According to the cancer stem cell hypothesis, there exists a fraction of cancer cells, that is, cancer stem cells, responsible for tumor maintenance and therapeutic failure. Herein we investigated the involvement of proto-oncogene Pim-3 in driving the stemness properties in pancreatic cancer. Expression levels of several stemness-associated markers were examined in several pancreatic cancer cell lines. The double positive (CD24+ESA+) and double negative (CD24-ESA-) pancreatic cancer cells were isolated from PANC-1 and L3.6pl, and their self-renewal ability, tumorigenicity as well as sensitivity to gemcitabine were then evaluated. Results showed that there existed heterogeneity in expression levels of stemness-associated surface markers among pancreatic cancer cell lines. CD24+ESA+ pancreatic cancer cells exhibited increased tumorigenicity and decreased chemosensitivity to gemcitabine as compared to CD24-ESA-cells. Besides, the double positive (CD24+ESA+) subpopulation also exhibited greater expression level of Pim-3 when compared with the double negative (CD24-ESA-) ones. Furthermore, silencing of Pim-3 in pancreatic cancer cells leads to decreased proportions of both single positive (CD24+ and ESA+) and double positive (CD24+ESA+) pancreatic cancer cells. Overexpression of Pim-3 was associated with increased levels of some stemness-associated transcription factors (STAT3, etc.). Moreover, the phosphorylation level and transcriptional activity of STAT3 were decreased in Pim-3 silenced pancreatic cancer cells and restoration of its activity results in restitution of stem cell-like phenotypes. Therefore, Pim-3 maintains stemness of pancreatic cancer cells via activating STAT3 signaling pathway and might be used as a novel therapeutic target in pancreatic cancer.

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Expression of Pim-3 in colorectal cancer and its relationship with prognosis

Effects of PIM3 in Prognosis of Colon Cancer

Prognostic and Immunomodulatory Effects of PIM1 in Colorectal Carcinoma.

TAB3 Upregulates PIM1 Expression by Directly Activating the TAK1-STAT3 Complex to Promote Colorectal Cancer Growth.

Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis.

PIM3 Promotes the Proliferation and Migration of Acute Myeloid Leukemia Cells

Proto-Oncogene Serine/Threonine Kinase PIM3 Promotes Cell Migration Via Modulating Rho GTPase Signaling

Pim-3 Contributes to Radioresistance Through Regulation of the Cell Cycle and DNA Damage Repair in Pancreatic Cancer Cells

Pim-3 as a potential predictor of chemoradiotherapy resistance in locally advanced rectal cancer patients

Pim1 Supports Human Colorectal Cancer Growth During Glucose Deprivation by Enhancing the Warburg Effect.

Pathophysiological Roles of Pim-3 Kinase in Pancreatic Cancer Development and Progression.

Pim-3 Regulates Stemness of Pancreatic Cancer Cells Via Activating Stat3 Signaling Pathway

PIM3 Kinase: A Promising Novel Target in Solid Cancers

Aberrant Expression of Pim-3 Promotes Proliferation and Migration of Ovarian Cancer Cells

Proto-oncogene, Pim-3 with serine/threonine kinase activity, is aberrantly expressed in human colon cancer cells and can prevent Bad-mediated apoptosis.

Dual roles of TRIM3 in colorectal cancer by retaining p53 in the cytoplasm to decrease its nuclear expression

Potential role of TRIM3 as a novel tumour suppressor in colorectal cancer (CRC) development

Roles of Pim-3, a Novel Survival Kinase, in Tumorigenesis.

The Relationship Between Pim-3 Expression and Chemoradiotherapy Resistance in Locally Advanced Rectal Cancer Patients.

Effect of IMP3 on Epithelial-to-mesenchymal Transition and the Function of Colon Cancer Stem Cells.